Regional
Illinois Region VIII Emergency Medical Services
An undated version is under review. The figures below are from the current listed document.
Drugs and doses35
A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Cefazolin7
Acetaminophen
Adenosine
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 5 mg | NEB | not captured | standing | page 213 · source |
| Other | adult | 2.5 mg | NEB | not captured | standing | pages 25, 139 · source |
| Other | peds | 2.5 mg | NEB | not captured | standing | pages 25, 139 · source |
| Respiratory distress | adult | 2.5–3 mg | NEB | not captured | standing | page 25 · source |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 300 mg | IV/IO | not captured | standing | pages 40, 49, 50, 151, 214 · source |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | pages 40, 49, 50, 151, 214 · source |
| Post-ROSC care | adult | 150 mg | IV/IO | not captured | standing | pages 44, 214 · source |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 51, 214 · source |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 324 mg | PO | not captured | standing | pages 48, 215 · source |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 36, 37, 146 · source |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 36, 37, 146 · source |
| Other | adult | 2 mg | IV/IO | not captured | standing | pages 80, 175 · source |
| Other | adult | 2–6 mg | IV/IM | not captured | standing | pages 77, 78, 173 · source |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 80, 175 · source |
| Other | peds | 0.05 mg/kg | IV/IM | not captured | standing | pages 77, 78, 173 · source |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 g | IV | not captured | standing | pages 103, 218 · source |
D–F Dextrose, Diazepam, Diphenhydramine, Dopamine, Epinephrine, Etomidate, Fentanyl7
Dextrose
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–20 mg | PR | not captured | standing | pages 164, 220 · source |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 50 mg | IV/IO/IM | not captured | standing | pages 55, 221 · source |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 55, 221 · source |
| Anaphylaxis | adult | 50 mg | IV/IO/IM | not captured | standing | pages 56, 221 · source |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 56, 221 · source |
Dopamine
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.1 mg | IV/IO | not captured | standing | pages 56, 156, 224 · source |
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 56, 156, 223 · source |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 56, 156, 223 · source |
| Anaphylaxis | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 56, 156, 224 · source |
| Bradycardia | peds | 0.1 mL/kg | IV/IO | not captured | standing | pages 146, 224 · source |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 34, 35, 40, 49, 50, 144, 151, 224 · source |
| Cardiac arrest | peds | 0.1 mL/kg | IV/IO | not captured | standing | pages 34, 35, 40, 49, 50, 144, 151, 224 · source |
| Other | adult | 100 mcg | IV/IO | not captured | standing | pages 44, 224 · source |
| RSI induction | adult | 100 mcg | IV/IO | not captured | standing | pages 27, 29, 31, 224 · source |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.6 mg/kg | IV/IO | not captured | standing | pages 27, 29, 31 · source |
G–L Glucagon, Hydroxocobalamin, Ipratropium, Ketamine, Ketorolac, Levalbuterol, Lidocaine7
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV | not captured | standing | pages 71, 167, 227 · source |
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV | not captured | standing | pages 72, 168, 227 · source |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.5 mg | IV | not captured | standing | pages 71, 167, 227 · source |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.5 mg | IV | not captured | standing | pages 72, 168, 227 · source |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | pages 60, 158, 227 · source |
| Hypoglycemia | peds | 1 mg | IM | not captured | standing | pages 60, 158, 227 · source |
Hydroxocobalamin
Ipratropium
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV/IO | not captured | standing | pages 66, 231 · source |
| Other | adult | 50 mg | IV/IO | not captured | standing | pages 33, 137, 231 · source |
| Other | adult | 50 mg | IV/IO | not captured | standing | page 43 · source |
| Other | peds | 0.5 mg/kg | IV/IO | not captured | standing | pages 33, 137, 231 · source |
| Mild to moderate pain | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 64, 65, 163, 231 · source |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 64, 65, 163, 231 · source |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | pages 27, 29, 31, 136, 231 · source |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | pages 27, 29, 31, 136, 231 · source |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV/IM | not captured | standing | pages 64, 232 · source |
Levalbuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.63 mg | NEB | not captured | standing | pages 25, 233 · source |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| VF / pulseless VT | adult | 1 mg/kg | IV/IO | not captured | standing | pages 41, 49, 50, 151, 152, 234 · source |
| VF / pulseless VT | adult | 1 mg/kg | IV/IO | not captured | standing | pages 41, 49, 50, 151, 152, 234 · source |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | pages 41, 49, 50, 151, 152, 234 · source |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | pages 41, 49, 50, 151, 152, 234 · source |
M–O Magnesium Sulfate, Midazolam, Morphine, Naloxone, Nitroglycerin, Ondansetron, Oral Glucose7
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | pages 25, 139, 235 · source |
| Asthma / bronchospasm | peds | 25 mg/kg | IV | not captured | standing | pages 25, 139, 235 · source |
| Eclampsia / pre-eclampsia | adult | 2 g | IV/IO | not captured | standing | pages 133, 235 · source |
| Other | adult | 2 g | IV/IO | not captured | standing | pages 42, 46, 235 · source |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IO | not captured | standing | page 57 · source |
| Agitation | adult | 2.5 mg | IM | not captured | standing | page 57 · source |
| Eclampsia / pre-eclampsia | adult | 2 mg | IV/IO | not captured | standing | page 133 · source |
| Other | adult | 2 mg | IV/IO | not captured | standing | pages 33, 137 · source |
| Other | adult | 2 mg | IV/IO | not captured | standing | pages 66, 164 · source |
| Other | adult | 2 mg | IV/IO | not captured | standing | pages 97, 191 · source |
| Other | adult | 2 mg | IV/IO/IM/IN | not captured | standing | page 196 · source |
| Other | adult | 2.5 mg | IM/IN | not captured | standing | pages 66, 164 · source |
| Other | adult | 2.5 mg | IM/IN | not captured | standing | pages 97, 191 · source |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 33, 137 · source |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 66, 164 · source |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 97, 191 · source |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 196 · source |
| Other | peds | 0.2 mg/kg | IN | not captured | standing | page 137 · source |
| Other | peds | 0.2 mg/kg | IM/IN | not captured | standing | pages 66, 164 · source |
| Other | peds | 0.2 mg/kg | IM/IN | not captured | standing | pages 97, 191 · source |
| Mild to moderate pain | adult | 2 mg | IV/IO/IM/IN | not captured | standing | page 236 · source |
| RSI induction | adult | 5 mg | IV/IO | not captured | standing | pages 27, 29, 31 · source |
Morphine
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 1 mg | IV/IO | not captured | standing | pages 79, 174, 238 · source |
| Opioid overdose | adult | 2 mg | IN | not captured | standing | pages 79, 174, 238 · source |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 79, 174, 238 · source |
| Opioid overdose | peds | 2 mg | IN | not captured | standing | pages 79, 174, 238 · source |
Nitroglycerin
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV | not captured | standing | pages 53, 54, 154, 196, 241 · source |
| Nausea / vomiting | adult | 4 mg | PO | not captured | standing | pages 53, 54, 154, 196, 241 · source |
| Nausea / vomiting | peds | 2 mg | IV | not captured | standing | pages 53, 54, 154, 196, 241 · source |
| Nausea / vomiting | peds | 4 mg | PO | not captured | standing | pages 53, 54, 154, 196, 241 · source |
P–R Pralidoxime, Proparacaine2
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 1800 mg | IV/IM | not captured | standing | pages 78, 173 · source |
| Nerve agent exposure | peds | 1800 mg | IV/IM | not captured | standing | pages 78, 173 · source |
| Other | adult | 600 mg | IM | not captured | standing | pages 78, 173 · source |
| Other | adult | 600–1200 mg | IM | not captured | standing | pages 78, 173 · source |
| Other | peds | 15 mg/kg | IM | not captured | standing | pages 78, 173 · source |
| Other | peds | 15 mg/kg | IM | not captured | standing | pages 78, 173 · source |
S–Z Sodium Bicarbonate, Succinylcholine, Terbutaline, Tetracaine, Tranexamic Acid5
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 50 mEq | IV/IO | not captured | standing | pages 40, 50, 243 · source |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 69, 243 · source |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 76, 172, 243 · source |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 81, 176, 243 · source |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 106, 243 · source |
| Other | adult | 50 mEq | IV/IO | not captured | standing | pages 105, 198, 243 · source |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 76, 172, 243 · source |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 81, 176, 243 · source |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | pages 32, 244 · source |
Terbutaline
Tetracaine
Cite this
Illinois Region VIII Emergency Medical Services, United States EMS Protocol Census. 127 dose entries, effective 2025-01-01.
https://protoquiz.com/census/agencies/illinois-region-viii-emergency-medical-services/
The census is free and not for sale. Only public agencies are named.